NewKerala.com

Healthcare Revolution: Why Private Sector Must Join India's Medical Mission

The Union Minister stressed that healthcare must reduce its reliance on government funding. He called for greater private sector involvement to achieve global healthcare standards. Successful examples like indigenous gene therapy and vaccine development demonstrate this approach works. The minister believes this shift will drive India's growth in science and technology through innovation and collaboration.

Key Points: Minister Calls for Private Sector Role in Healthcare Reform

  • Minister emphasizes integration between academia, research and industry partnerships
  • Cites successful gene therapy trial for Haemophilia as PPP model
  • Highlights India's vaccine exports to nearly 200 countries globally
  • Notes Rs 50,000 crore ANRF funding with major private contribution
2 min read

Healthcare must enable more private sector participation to attain global benchmarks: Minister

Union Minister advocates reduced government dependence, more private participation in healthcare to achieve global standards and boost medical research collaboration.

"The healthcare sector must move away from overdependence on government funding and encourage a culture of extensive private-sector participation - Union Minister Jitendra Singh"

New Delhi, Oct 24

The healthcare sector must move from overdependence on government funding and enable private participation to attain global benchmarks, said Union Minister of State (Independent Charge) for Science & Technology on Friday.

New Delhi, Oct 24 (IANS) The healthcare sector must move from overdependence on government funding and enable private participation to attain global benchmarks, said Union Minister of State (Independent Charge) for Science & Technology on Friday. He was speaking while inaugurating the Diabetes Conference "TREAT-DM 2025 – Translational Research, Adiposopathy, Technology for Diabetes and Metabolic Diseases" through a virtual address at the J N Tata Auditorium.

“The healthcare sector must move away from overdependence on government funding and encourage a culture of extensive private-sector participation for synergised healthcare, philanthropy, and collaboration to achieve global benchmarks in healthcare research,” Singh said.

The MoS emphasised that the age of working in silos is over, adding that integration between academia, research, and industry is the way forward.

“The boundary between public and private sectors has gradually faded. Thanks to Prime Minister Modi’s reforms, India has opened its space, nuclear, and biotechnology sectors for wider participation, leading to historic outcomes,” he said.

He cited examples of public-private participation, such as the country’s first-ever successful indigenous gene-therapy trial for Haemophilia, conducted under the Department of Biotechnology in collaboration with Christian Medical College, Vellore; the first indigenously discovered antibiotic Nafithromycin effective against resistant respiratory infections, particularly in diabetic and immunocompromised patients, developed through collaboration between government and industry partners.

Singh recalled India’s success in vaccine research and export.

“Our indigenously developed DNA vaccine and other vaccines have been supplied to nearly 200 countries. This reflects India’s dual commitment to self-reliance and global welfare – the spirit of Vishwabandhu Bharat,” he said.

The Union Minister also underlined that India’s Anusandhan National Research Foundation (ANRF) is structured to ensure sustainable funding with Rs 50,000 crore earmarked for five years, of which Rs 36,000 crore will come from non-governmental sources. This is a remarkable shift toward building a self-sustainable research model that mirrors global best practices, he added.

Urging researchers to align their efforts with the vision of Viksit Bharat at 2047, the Minister stated that “India’s growth in science and technology will be driven by innovation, self-reliance, and international collaboration”.

- IANS

Share this article:

Reader Comments

R
Rohit P
While private participation is good, we must ensure healthcare remains affordable for common people. The government should regulate prices so that quality treatment doesn't become a luxury.
A
Arjun K
Excellent vision! The Rs 50,000 crore ANRF funding with major private contribution shows we're serious about research. India's vaccine success proves we can lead globally. 🚀
S
Sarah B
Integration between academia, research and industry is crucial. We've seen how this model works in developed countries. Good to see India adopting global best practices.
K
Karthik V
The indigenous gene therapy and antibiotic development examples are impressive. This is exactly what we need - homegrown solutions for Indian healthcare challenges.
M
Michael C
As someone working in healthcare research, I appreciate the focus on sustainable funding models. The 36,000 crore from non-government sources will drive innovation significantly.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50